Jonathan E. Schoenhals

Statistics

Publications

Citations

1.1K

H-Index

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Southwestern Medical Center

First Hospital of China Medical University

The Ohio State University

Harold C. Simmons Comprehensive Cancer Center

Jonathan E. Schoenhals is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2016–2024

Publications

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy

Xiaohong Wang, Jonathan E. Schoenhals, Ailin Li et al. · Cancer Research · 2016 · 271 citations · Full text

Medicine, Immunology, Oncology +17

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed Younes et al. · Journal for ImmunoTherapy of Cancer · 2020 · 212 citations · Full text

Medicine, Immunology, Oncology +17

Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer

Yuanyuan Zhang, Jonathan E. Schoenhals, Alana Christie et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 97 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells

Ailin Li, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals et al. · Cancer Letters · 2018 · 92 citations

Medicine, Oncology, Pharmacology +16

Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian et al. · Clinical Cancer Research · 2019 · 82 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 13